ORG 4094
Latest Information Update: 08 Jan 2001
Price :
$50 *
At a glance
- Originator Organon
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 08 Jan 2001 Discontinued-Preclinical for Autoimmune disorders in Netherlands (Unknown route)